Telomir Pharmaceuticals, Inc./$TELO
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
Ticker
$TELO
Sector
Primary listing
Employees
-
Headquarters
Website
TELO Metrics
BasicAdvanced
$48m
-
-$0.33
-0.65
-
Price and volume
Market cap
$48m
Beta
-0.65
52-week high
$3.10
52-week low
$1.05
Average daily volume
182k
Financial strength
Current ratio
5.141
Quick ratio
5.103
Total debt to equity
8.012
Profitability
Management effectiveness
Return on assets (TTM)
-152.03%
Return on equity (TTM)
-317.65%
Valuation
Price to book
8.14
Price to tangible book (TTM)
8.14
Price to free cash flow (TTM)
-12.015
Free cash flow yield (TTM)
-8.32%
Free cash flow per share (TTM)
-0.117
Growth
Earnings per share change (TTM)
-41.22%
3-year earnings per share growth (CAGR)
117.81%
TELO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Telomir Pharmaceuticals, Inc. stock?
Telomir Pharmaceuticals, Inc. (TELO) has a market cap of $48M as of May 04, 2026.
What is the P/E ratio for Telomir Pharmaceuticals, Inc. stock?
The price to earnings (P/E) ratio for Telomir Pharmaceuticals, Inc. (TELO) stock is 0 as of May 04, 2026.
Does Telomir Pharmaceuticals, Inc. stock pay dividends?
No, Telomir Pharmaceuticals, Inc. (TELO) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Telomir Pharmaceuticals, Inc. dividend payment date?
Telomir Pharmaceuticals, Inc. (TELO) stock does not pay dividends to its shareholders.
What is the beta indicator for Telomir Pharmaceuticals, Inc.?
Telomir Pharmaceuticals, Inc. (TELO) has a beta rating of -0.65. This means that it has an inverse relation to market volatility.